@Davisite, I'm not sure if this has been asked and I've missed it, but are you able to elaborate on what we should expect from the toxicology studies?
For example, I assume the outcome is not "RC220 passes or (heaven forbid) fails" and therefore can/can't be used in clinical trials. I would also assume that we should expect the studies will show that RC220 is toxic, with the level of toxicity being dependent on the dose given.
But other than a delay, is there anything else that can go wrong with these studies? Is it possible to get a great / good / bad result for RC220 and if so what would those scenarios look like?
Thanks in advance.
General Comments / Chat, page-10733
-
- There are more pages in this discussion • 316 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.095(5.44%) |
Mkt cap ! $281.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.62 | $285.9K | 170.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16759 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 12047 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |